| 201 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
| 202 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
| 203 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
| 204 |
Boehringer Ingelheim International GMBH et al v. Mylan Pharmaceuticals Inc. |
1:05-cv-00854 |
D.Del. |
|
|
|
|
| 205 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
| 206 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
| 207 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
| 208 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
| 209 |
CEPHALON, INC. v. MYLAN PHARMACEUTICAL, et al |
2:03-cv-01394 |
D.N.J. |
|
|
|
|
| 210 |
Merck & Co., Inc. v. Mylan Pharmaceutical |
1:03-cv-01953 |
S.D.N.Y. |
|
|
|
|
| 211 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
| 212 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
| 213 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
| 214 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
| 215 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
| 216 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
| 217 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
| 218 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
| 219 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
| 220 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
| 221 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
| 222 |
Bristol-Myers Squibb v. Mylan Pharmaceut., et al |
1:01-cv-00414 |
S.D.N.Y. |
|
|
|
|
| 223 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
| 224 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
| 225 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
| 226 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
| 227 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
| 228 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
| 229 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
| 230 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
| 231 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
| 232 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICAL |
2:00-cv-01657 |
D.N.J. |
|
|
|
|